News
Novo Nordisk (NYSE:NVO) has filed for U.S. approval of an oral version of its blockbuster weight loss drug Wegovy, the company confirmed to BioPharma Dive. The Danish drugmaker disclosed the ...
Barchart on MSN17h
Jim Cramer Says You Should Buy This ‘Strong Buy’ Stock ‘Hand Over Fist’Eli Lilly (LLY) is a leading pharmaceutical company that discovers, develops, manufactures, and markets healthcare products.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback